Search - tctmd.com

Displaying 641 - 660 of 862

Sort: Relevancy | Date

Presentation The Structural Heart Disease Summit 2018

Evolut R Low-Risk

Presenter: Jeffrey J. Popma

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Partner 3 Low-Risk

Presenter: Martin B. Leon

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Presenter: Eberhard Grube, Tamim Nazif

June 21, 2018

News Daily News

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Michael O'Riordan

June 20, 2018

News Daily News

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

Shelley Wood

June 18, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for May 2018

Caitlin E. Cox

June 01, 2018

News Conference News EuroPCR 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Caitlin E. Cox

May 25, 2018

News Conference News EuroPCR 2018

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Yael L. Maxwell

May 24, 2018

News Conference News EuroPCR 2018

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

Caitlin E. Cox

May 23, 2018

News Conference News EuroPCR 2018

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Shelley Wood

May 17, 2018

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Todd Neale

May 14, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for April 2018

Caitlin E. Cox

April 30, 2018

News Conference News SCAI 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Shelley Wood

April 28, 2018

News Conference News SCAI 2018

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

Shelley Wood

April 27, 2018

News Daily News

Real-World AV Replacement in France: All Eyes on Mortality as Volumes Go Up and Patient Risk Declines

Yael L. Maxwell

April 10, 2018

News Daily News

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

Todd Neale

April 03, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2018

Shelley Wood

April 02, 2018

News Daily News

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

Yael L. Maxwell

March 26, 2018

News Conference News CRT 2018

Ticagrelor: Better Platelet Blockade Post-TAVR?

Michael O'Riordan

March 07, 2018

News Conference News CRT 2018

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Michael O'Riordan

March 05, 2018

Advertisement

Evolut R Low-Risk

Partner 3 Low-Risk

Keystone TRIGUARD Cerebral Embolic Protection During TAVR: New Generation Devices and the Status of Ongoing Clinical Trials

Leaflet Thrombosis After TAVR Not Linked With Stroke, TIA, or Mortality Risk

Percutaneous Edge-to-Edge Repair for Tricuspid Regurgitation: Some Successes, Some Caveats

TCTMD’s Top 10 Most Popular Stories for May 2018

Real-World Sapien 3 Results Match Trial Experience in Intermediate-Risk Patients

Pace Quickens for Mitral Device Innovation for Repair, Replacement

Embolic Protection in TAVR: Signs of Benefit, but Road Map for Use Still Uncharted

EuroPCR 2018: Stable CAD, Functional Tests, and Renal Denervation Take Center Stage

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

TCTMD’s Top 10 Most Popular Stories for April 2018

Debate Over Cerebral Protection in TAVR Fizzles in the Face of Reimbursement Hopes

Heart Function, QoL Improvements at 1 Year in US Postapproval MitraClip Registry: PAS-1

Real-World AV Replacement in France: All Eyes on Mortality as Volumes Go Up and Patient Risk Declines

Device Thrombus After LAA Closure Strongly Linked to Stroke in Real-World Registry

TCTMD’s Top 10 Most Popular Stories for March 2018

New Surgical Valve Durability Data Set ‘Critical Benchmark’ for TAVR Devices

Ticagrelor: Better Platelet Blockade Post-TAVR?

Early Low-Risk TAVR Data Reassure, but Durability Questions Remain

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content